Hepatitis C Treatment in Chicago, IL
We are happy to report, Digestive Health Services, along with University of Chicago and Northwestern, have completed one of several clinical studies that has lead to FDA approval for the latest treatment for Hepatitis C infected patients. The new drug, Harvoni, a combination of Sofosbuvir and Ledipasvir, provides an amazing 90-100% cure rate of HCV infections, with minimal adverse events. There are many additional new therapies and advancements in the treatment of HCV, that will be approved soon.
